Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher disease

Paul Carango, Vicky L. Funanage, Rubén E. Quirós, Craig S. Debruyn, Harold G. Marks

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Pelizaeus‐Merzbacher disease is a rare, sex‐linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene. Only 25% of patients studied with Pelizaeus‐Merzbacher disease have exonic mutations in this gene; the underlying cause of the disease in the remaining patients is unknown. The PLP gene encodes two major alternatively spliced transcripts called PLP and DM20. PLP messenger RNA is specifically expressed in central nervous system tissue, whereas DM20 messenger RNA is found in central nervous system, cardiac, and other tissues. We studied cultured skin fibroblasts from 2 brothers with Pelizaeus‐Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene. Examination of RNA from these cells showed that the level of DM20 messenger RNA is elevated sixfold relative to male control skin fibroblasts. An unrelated female carrier, also with no detectable exonic mutation, showed a threefold increase in DM20 messenger RNA in cultured skin fibroblasts. Our findings suggest that in some patients, Pelizaeus‐Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier.

Original languageEnglish (US)
Pages (from-to)610-617
Number of pages8
JournalAnnals of Neurology
Volume38
Issue number4
DOIs
StatePublished - Oct 1995

Fingerprint

Proteolipids
Siblings
Messenger RNA
Mutation
Fibroblasts
Proteins
Skin
Central Nervous System
Myelin Proteolipid Protein
Nerve Tissue
Central Nervous System Diseases
Genes
RNA

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher disease. / Carango, Paul; Funanage, Vicky L.; Quirós, Rubén E.; Debruyn, Craig S.; Marks, Harold G.

In: Annals of Neurology, Vol. 38, No. 4, 10.1995, p. 610-617.

Research output: Contribution to journalArticle

Carango, Paul ; Funanage, Vicky L. ; Quirós, Rubén E. ; Debruyn, Craig S. ; Marks, Harold G. / Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher disease. In: Annals of Neurology. 1995 ; Vol. 38, No. 4. pp. 610-617.
@article{684460de141b4ad5929449fd39565b32,
title = "Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher disease",
abstract = "Pelizaeus‐Merzbacher disease is a rare, sex‐linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene. Only 25{\%} of patients studied with Pelizaeus‐Merzbacher disease have exonic mutations in this gene; the underlying cause of the disease in the remaining patients is unknown. The PLP gene encodes two major alternatively spliced transcripts called PLP and DM20. PLP messenger RNA is specifically expressed in central nervous system tissue, whereas DM20 messenger RNA is found in central nervous system, cardiac, and other tissues. We studied cultured skin fibroblasts from 2 brothers with Pelizaeus‐Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene. Examination of RNA from these cells showed that the level of DM20 messenger RNA is elevated sixfold relative to male control skin fibroblasts. An unrelated female carrier, also with no detectable exonic mutation, showed a threefold increase in DM20 messenger RNA in cultured skin fibroblasts. Our findings suggest that in some patients, Pelizaeus‐Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50{\%} increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier.",
author = "Paul Carango and Funanage, {Vicky L.} and Quir{\'o}s, {Rub{\'e}n E.} and Debruyn, {Craig S.} and Marks, {Harold G.}",
year = "1995",
month = "10",
doi = "10.1002/ana.410380409",
language = "English (US)",
volume = "38",
pages = "610--617",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Overexpression of DM20 messenger RNA in two brothers with pelizaeus‐merzbacher disease

AU - Carango, Paul

AU - Funanage, Vicky L.

AU - Quirós, Rubén E.

AU - Debruyn, Craig S.

AU - Marks, Harold G.

PY - 1995/10

Y1 - 1995/10

N2 - Pelizaeus‐Merzbacher disease is a rare, sex‐linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene. Only 25% of patients studied with Pelizaeus‐Merzbacher disease have exonic mutations in this gene; the underlying cause of the disease in the remaining patients is unknown. The PLP gene encodes two major alternatively spliced transcripts called PLP and DM20. PLP messenger RNA is specifically expressed in central nervous system tissue, whereas DM20 messenger RNA is found in central nervous system, cardiac, and other tissues. We studied cultured skin fibroblasts from 2 brothers with Pelizaeus‐Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene. Examination of RNA from these cells showed that the level of DM20 messenger RNA is elevated sixfold relative to male control skin fibroblasts. An unrelated female carrier, also with no detectable exonic mutation, showed a threefold increase in DM20 messenger RNA in cultured skin fibroblasts. Our findings suggest that in some patients, Pelizaeus‐Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier.

AB - Pelizaeus‐Merzbacher disease is a rare, sex‐linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene. Only 25% of patients studied with Pelizaeus‐Merzbacher disease have exonic mutations in this gene; the underlying cause of the disease in the remaining patients is unknown. The PLP gene encodes two major alternatively spliced transcripts called PLP and DM20. PLP messenger RNA is specifically expressed in central nervous system tissue, whereas DM20 messenger RNA is found in central nervous system, cardiac, and other tissues. We studied cultured skin fibroblasts from 2 brothers with Pelizaeus‐Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene. Examination of RNA from these cells showed that the level of DM20 messenger RNA is elevated sixfold relative to male control skin fibroblasts. An unrelated female carrier, also with no detectable exonic mutation, showed a threefold increase in DM20 messenger RNA in cultured skin fibroblasts. Our findings suggest that in some patients, Pelizaeus‐Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier.

UR - http://www.scopus.com/inward/record.url?scp=0029155690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029155690&partnerID=8YFLogxK

U2 - 10.1002/ana.410380409

DO - 10.1002/ana.410380409

M3 - Article

C2 - 7574457

AN - SCOPUS:0029155690

VL - 38

SP - 610

EP - 617

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 4

ER -